Abstract
Background
Cervical cancer in women is the second most common cancer worldwide next to breast cancer. This is considered as a vital reproductive health problem in women and a prime cause of mortality among young women [1] . Global report published by WHO in 2014, shows almost 266,000 women died from cancer of the cervix in the year 2012 [2] .Worldwide the Impact of cervical cancer on women's life is indubitable [1] . Especially developing countries are the worst hit by this preventable disease which is considered as a significant public health concern. According to a report, more than 83% of 493,000 new cases of cervical cancer and higher mortality rate are seen in developing countries [3] . The main reason is lack of effective screening programs which can detect and treat preliminary stage of this life threatening disease [4] . According to the China Cancer Registration Annual Report 2004, cervical cancer was in the 8th position for the cause of malignancy among women, with a crude incidence rate of 8.55 per 100,000 women [5] .A report by Ferlay et al. showed that cervical cancer is a major health challenge in Bangladesh and it constitutes 17,686 new cases each year, an estimated 10,364 deaths annually [6] .Among Pakistani women, cervical cancer is the fourth most common type of cancer; with an age standardized risk (ASR) of 7.5 per 100,000 women and the incidence of disease burden is likely to be on the rise [7] .A study in Malaysia showed that cervical cancer is the third most common cancer among women, as an estimated 8.4% of all women cancers [8] .According to a survey in Korea, cervical cancer was accounted for 9.8% of all new cancer cases in 2002, with a total number of 4,500 invasive cervical cancer (ICC) cases and 3,000 carcinoma in situ (CIS) cases [9, 10] . A report on human papilloma virus (HPV) and cancer shows that every year in India, 122,844 women are diagnosed with cervical cancer and 67,477 die from the disease. A large number of females (432.2 million) aged 15 years and older are the most vulnerable. Among all the South Asian countries, India has the highest age standardized incidence of cervical cancer at 22, compared to 19.2 in Bangladesh, 13 in Sri Lanka, and 2.8 in Iran. So, this is a crucial time to understand the epidemiological pattern and diagnoseproperly cervical cancer cases in India [11] . Pap test is named after George Papanicolaou, who introduced it as a cervical screening test in 1943. This is a very simple, quick noninvasive, painless procedure. Clinician collects cellular sample from in and around the cervix by a wooden scraper. Afterwards the sample is placed on a glass slide and rinsed in liquid fixative and finally stained for cytological examination [12, 13] . The major advantage of Pap test is the detection of cervical cancer at an early stage and its cost-effectiveness. Developed countries widely use it which minimized the incidence and mortality of this disease at least 70%. Well organized screening programmes, accessibility to treatment, reduction in parity, and other risk factors also contributed to achieve this goal [13] .As cervical cancer has a pre malignant phase, which could extend for several years, so repeated Pap tests are strongly recommended to reduce the impact of individual false negative rate.
Figure -1
Age adjusted incidence rates of cervix uterifemales (rate per 100,000) in the various populations of India based cancer registries [14] .
Although there are different research works carried out on cervical cancer from different parts of India, but no peer reviewed literatures are available from Rourkela, Odisha state. The 2010 age-adjusted rate for cervical cancer in the various registries are indicated in Figure 1 [14] . This study was undertaken to facilitate early diagnosis of cervical cancer and to determine the accuracy of Pap test by correlating with histopathology, as well as clinically compare to evaluate sensitivity, specificity and positive predictive value of Pap smear.
Material and Methods

Study Period
This study was conducted in two years period, September 2010 to September 2012.
Study design and the participants
Out of 417 Pap smears performed104 cases underwent both Pap test as well as biopsy and were included in this study. Experimentation was done in Ispat General Hospital, Rourkela, Odisha, India.
Experimentation and data collection
At the beginning of the experimentation, it was confirmed that patient was not menstruating, passed 10-20 days of her menstrual cycle, and had not douched or used tampons or vaginal medication in past 24 hours. Patients were placed in the lithotomy position and the procedure was done by the study investigator Dr. Reena Naik, in assistance of a well trained and experienced nurse/midwife. An unlubricated sterile Cusco's bivalve speculum was introduced to observe the cervix, in ample light condition. Then with the help of Endocervical brush/Ayre's spatula, transformation zone was scraped by rotating the spatula in clock wise direction in squamo columnar junction, and endocervical smear were made on a clean slide and fixed with 95% ethyl alcohol for at least 15 minutes. Afterwards the smear was send to laboratory for conventional Papanicolaou staining, in which tinctorial dyes and acids are selectively retained by cells. Unstained cells are invisible under light microscope [15, 16] .The Pap smears were interpreted in the Department of Pathology, by two pathologists according to Bethesda 2001 classification [17] and for histology WHO classification was used [18] .Once the cytology specimen was collected, the cervix was painted with a cotton wool soaked in 3-5% VIA and examined after 1 min for aceto-white reaction. Any suspicious or visible lesions were then biopsied. Some patients with abnormal positive Pap smear results were also called back for tissue biopsy. These patients were referred for proper follow up and management in the gynaecological clinic.
Inclusion criteria
Patients with chief complaints of backache, hypogastric pain, pain during sexual intercourse, postcoital bleeding, discharge from vagina, were included in the study for Pap screening.
Exclusion criteria
Patients who refused to participate; patients having vaginal bleeding other than postcoital and postmenopausal were excluded. Patients with abnormal result from previous screening, those with any visible mass/lesions before application of VIA on the cervix were not considered. Patients with metastatic disease, double primary cancers, and other comorbid conditions such as diabetes, hypertension, ischemia, tuberculosis, autoimmune disorder were excluded for biasness.
Ethical committee approval
Individual consent was obtained from the participants before the smear was taken. Approval for the study was obtained from the review board of ethical committee of the Institution (Reference number -40/dated 28-02-11). The present research was conducted according to the declaration of Helsinki (Latest version).
Sample size calculation
Jain et al., 2012 done a study and it showed sensitivity of the pap smear test was 78%, with Precision 10%, Desired confidence level (%)= 95, the no. of diseased subjects needed for the current study was 66 [19] .
Outcome variable
Presence of abdominal pain, bleeding P/V, P/V discharge, weight loss, pelvic organ prolapse, vaginal burning and itching, inflammation, atypical squamous cell of undetermined significance (ASCUS), low grade squamous intraepithelial neoplasia (LSIL), high grade squamous intraepithelial neoplasia (HSIL), carcinoma were set up as outcome variable.
Explanatory variables
The demographic factors age, caste, religion, etc. were considered as explanatory variables.
Data management and statistical analysis
Data analysis and interpretation was done by descriptive statistics. T test was performed to obtain the statistical significance between the variables. Statistical Package for Social Science (SPSS) software was used (Licensed version 16). Concordance rate for different lesions was calculated and given below:
Results
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Histological diagnosis
Concordance rate Normal (48.6%), Chronic cervicitis ( figure 2) (70.8%), CIN-I ( figure 3) (33.3%), CIN-II and III (figure 4) (100%), Malignancy (figure 5) (100%). Different statistical values of Pap-smear for different grades of diseases represented in table -5.Diagnostic accuracy was almost 100% for HSIL and malignancy except for PPV in HSIL which was 50%. Sensitivity and specificity was also moderately good for inflammatory lesions. Pap smear was least sensitive in diagnosing LSIL (30%), but specificity (94.5%) and diagnostic accuracy was good (88.2%). Overall statistical value of Pap smear in diagnosing cervical dysplasia, sensitivity, specificity, PPV, NPV and diagnostic accuracy were 79.4%,58.3%,86.1%,46.6% and74.5% respectively. Sensitivity and Diagnostic accuracy was moderately good, PPV was good, but NPV and specificity was quite low.
Discussion
Pap test has dramatically declined in the incidence of cervical cancer, a major health burden especially in underdeveloped nations such as Latin America and Southern Asia. As 35-55 years age group is the most vulnerable, so screening frequency should be increased based on resourcesto 'once every 10 years' and then 'once every 5 years'. 
Accuracy of Pap smear test in diagnosis of cervical lesions
In developing countries several attempts were made and targeted a smaller group, by camp approach, hospital-based screening, high-risk screening etc. The reason is difficulties of launching population-based programs.
Cytological and clinical findings in different age group
Most common age for carcinoma was 50-70 years and for dysplasia was 40-60 years. As the age progresses there is an increased incidence of dysplasia converting to carcinoma. The most common clinical presentation in our study was irregular bleeding P/V. We found most of the patients with post menopausal bleeding had frank carcinoma (5 out of 6) which was similar to another study by Lavanya et al. [20] Cyto-Histological Correlation In our study infected patients were treated with antibiotics then repeat Pap smear was done and bleeding P/V patients were directly recommended for it. The rates of concordance for individual lesion were calculated. The overall concordance rate of the study was 62(60.7%). The discordance case being 40(39.2%). The overall concordance rate is comparable with earlier findings [21] .Few earlier researchers Nawazet al. [22] , Yeoh et al. [23] , Rasbridge et al. [24] and Jain et al. [19] had reported concordance rate of 74%, 52%, 81.2% and 70% respectively. Concordance rate for squamous cell carcinoma in this study was 100% as compared to some previous reports (100%, 97.33%, 60% and 83.6%) [21] [22] [23] 19] .This could be due to the fact that most patients in developing countries come to the hospital in advanced stages.
Discrepancies & false negative rate
Jain et al. reported that discordance cases were under diagnosed or over diagnosed on cytology due to less cellularity with hemorrhagic background, air dying and fixation artifacts [19] . Another study showed that a main component of false negative rate appeared to be sampling and preparation artifacts [23] .So in order to decrease false negative rate, it is strongly recommended to repeat the smear at regular intervals. It has also been observed that error rate declined dramatically with 3 consecutive annual smears. Nawaz et al. reported that prime factors like air drying, blood or inflammation obscuring the cellularity were main causes for discrepancies [22] .Some researchers found interpretative error; sampling error and air drying were the reasons for under diagnosis [25, 26] . The concordance rate for CIN-I in present study was 33.3% corroborates with others [21-23; 19] .In this researchit was observed that CIN-I sensitivity was low but can be increased by adequate sampling and avoiding technical faults like drying and fixation artifacts and inflammations. This study shows significant correlation between Pap smear and cervical histology. This is clear from the findings that the PPV of Pap smear test was highest for malignancy. This was similar to reports by most other workers, where highest PPV (91.8%) was for malignancy. Statistical significance was also observed between cytology and histology [29] .
Conclusion
Pap smear is cost effective, non invasive screening test for early detection and management of cervicalcarcinoma. Present research confirmed its excellent sensitivity, specificity and PPV in detecting high grade lesion and carcinoma. Relatively lower CIN sensitivity can be improved by adequate sampling and avoiding technical errors. Bethesda system is strongly recommended for adequacy of sampling to minimize inconsistency. Regular screening should be advised to the patients. Govt. and NGOs can take a prime role by health education, campaigning and promotion about cervical cancer and its screening benefits at an early stage.
Limitations & future scope of the study
This study involved a limited time period of two years, and the sample size was less. Conducting broad spectrum multicentric studies in future is recommended. Automated liquidbased Pap cytology test was not performed, but it is common practice in developed countries. So future researchers may include this procedure which increases the detection rate for preneoplastic squamous intraepithelial lesions, when compared with the conventional Pap technique.
